Company / Operating Income per Share
Praxis Precision Medicines, Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$16.79
FY2025
5-year range
-$69.96 / -$3.94
FY2021-FY2025
Trend
+26.2%
vs FY2024
Sector context
#198 of 201
Health Care
What the data says
Among 201 Health Care companies, Praxis Precision Medicines, Inc. is in the bottom 1% for operating income per share. Operating Income per Share has increased for 3 consecutive years, from $-69.96 in FY2022 to $-16.79 in FY2025.
Based on SEC 10-K filings.
-16.79 in FY2025.
Improved from $-38.39 to $-16.79 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 201This company -$16.79 Sector average -$28.56
▼
+41.2% above sector average
Key checks
Key Insights
- Praxis Precision Medicines, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 26.2% year-over-year.
- Ranks #198 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$16.79 | +26.2% |
| FY2024 | -$22.77 | +40.7% |
| FY2023 | -$38.39 | +45.1% |
| FY2022 | -$69.96 | -1674.9% |
| FY2021 | -$3.94 | +43.1% |
| FY2020 | -$6.92 | +70.4% |
| FY2019 | -$23.40 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026